Diving into Mechanobiology in IPF: Exploring the Targeting of Tissue Mechanics to Halt Fibrosis Progression

• Examine how altered extracellular matrix stiffness and fibroblast mechanotransduction drive IPF pathogenesis
• Highlight mechanotherapeutic strategies designed to normalize aberrant cellular mechano-signaling and disrupt fibrotic feedback loops
• Discuss translational implications for developing therapies that not only slow disease but restore lung tissue function and improve patient outcomes.

Speakers:

David lagares

Chief Executive Officer, President & Founder

Zenon Biotech